Althea blames medical sales decline on TGA ‘falling asleep at the wheel’ amid ‘crazy’ antics of competitors by Steve Jones March 21, 2025March 26, 2025 Australia’s medical cannabis market has adopted a California-style approach to the drug, Althea chief executive Josh […]
Althea claims profitability ‘is close’ despite pharmaceutical nosedive by Steve Jones March 3, 2025March 4, 2025
Changes on the horizon but exit of pharmaceutical market ‘not currently on the table’, says Althea CEO by Steve Jones February 20, 2025February 20, 2025
Althea slashes revenue guidance and sales forecast, scraps vape project by Steve Jones February 13, 2025February 13, 2025
Althea resumes trading on ASX as board narrowly avoids a second shareholder revolt by Steve Jones February 3, 2025February 3, 2025
Althea set for court this week after detecting 14 breaches of ASX rules by Steve Jones January 28, 2025January 28, 2025
Althea sacks CFO days after praising his ‘continued dedication’ by Steve Jones December 18, 2024April 11, 2025
Althea committed to ‘transparency and corrective action’ after failure to lodge mandatory ASX notices by Steve Jones December 12, 2024December 12, 2024
Althea granted self-imposed ASX suspension amid failure to lodge notices to the market by Steve Jones December 5, 2024December 11, 2024